Aurora Cannabis Inc. (TSE:ACB – Free Report) – Roth Capital issued their Q1 2025 EPS estimates for Aurora Cannabis in a research note issued to investors on Monday, June 24th. Roth Capital analyst W. Kirk expects that the company will post earnings of ($0.03) per share for the quarter. The consensus estimate for Aurora Cannabis’ current full-year earnings is ($0.22) per share. Roth Capital also issued estimates for Aurora Cannabis’ Q2 2025 earnings at $0.10 EPS, Q3 2025 earnings at ($0.13) EPS, Q4 2025 earnings at $0.22 EPS and FY2025 earnings at $0.16 EPS.
Separately, ATB Capital cut their target price on shares of Aurora Cannabis from C$12.50 to C$11.00 and set a “sector perform” rating on the stock in a report on Friday, June 21st.
Aurora Cannabis Trading Down 2.8 %
TSE ACB opened at C$6.32 on Thursday. The company has a debt-to-equity ratio of 18.51, a quick ratio of 2.48 and a current ratio of 3.79. Aurora Cannabis has a one year low of C$3.84 and a one year high of C$15.50. The company has a 50-day simple moving average of C$8.66 and a 200-day simple moving average of C$5.06. The firm has a market capitalization of C$344.69 million, a PE ratio of -0.08 and a beta of 2.65.
About Aurora Cannabis
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Further Reading
- Five stocks we like better than Aurora Cannabis
- What Does Downgrade Mean in Investing?
- Qualcomm Stock: AI-Powered Growth Despite Volatility
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Salesforce Stock: Meeting Recap, AI Focus, and Forecast
- What to Know About Investing in Penny Stocks
- Is CAVA Overextended? A Closer Look at This High-Flying Stock
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.